The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma
- PMID: 11168756
- DOI: 10.1034/j.1600-0560.2001.280204.x
The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma
Abstract
Background: Syndecan-1 and E-cadherin are cell adhesion molecules which are expressed primarily on the surface of adult epithelial cells. They appear to be co-regulated and may act in concert to stabilize the epithelium. Loss of expression of both E-cadherin and syndecan-1 is seen in malignant transformation and invasion.
Methods: Thirteen cutaneous biopsies of acantholytic squamous cell carcinoma (SCC) were examined for coexpression of E-cadherin and syndecan-1.
Results: Interestingly, immunoreactivity for E-cadherin was increased in the in situ component while immunoreactivity for syndecan-1 was similar to that seen in normal skin. Conversely, in invasive SCC the expression of these two adhesion molecules was very similar. Both diminished with decreasing cell differentiation, as well as in the acantholytic areas where both molecules exhibited increasing cytosolic staining rather than cell membrane staining.
Conclusions: Our results suggest that it is likely E-cadherin and syndecan-1 act in concert to stabilize the epithelium and that the loss or decreased expression of both of these adhesion molecules is associated with malignant transformation.
Similar articles
-
Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma.J Cutan Pathol. 1999 Sep;26(8):386-90. doi: 10.1111/j.1600-0560.1999.tb01862.x. J Cutan Pathol. 1999. PMID: 10551410
-
The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.Mod Pathol. 2002 Jan;15(1):45-9. doi: 10.1038/modpathol.3880488. Mod Pathol. 2002. PMID: 11796840
-
Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin.Am J Clin Pathol. 2013 Apr;139(4):442-7. doi: 10.1309/AJCPTN4BNJYIRUWO. Am J Clin Pathol. 2013. PMID: 23525614
-
The role of syndecan-1 in malignancies.Ann Med. 1996 Feb;28(1):63-7. doi: 10.3109/07853899608999076. Ann Med. 1996. PMID: 8932508 Review.
-
Oral variant of acantholytic squamous cell carcinoma-Histochemical and immunohistochemical features.Acta Histochem. 2019 Nov;121(8):151443. doi: 10.1016/j.acthis.2019.151443. Epub 2019 Nov 6. Acta Histochem. 2019. PMID: 31706621 Review.
Cited by
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
-
A rare acantholytic variant of squamous cell carcinoma of the maxilla: A case report and literature review.Medicine (Baltimore). 2020 Aug 7;99(32):e21631. doi: 10.1097/MD.0000000000021631. Medicine (Baltimore). 2020. PMID: 32769927 Free PMC article. Review.
-
Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.Head Neck Pathol. 2020 Mar;14(1):230-238. doi: 10.1007/s12105-018-0987-2. Epub 2018 Nov 27. Head Neck Pathol. 2020. PMID: 30484070 Free PMC article.
-
Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.Dis Markers. 2015;2015:796052. doi: 10.1155/2015/796052. Epub 2015 Sep 1. Dis Markers. 2015. PMID: 26420915 Free PMC article. Review.
-
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.Oncotarget. 2015 Oct 6;6(30):28693-715. doi: 10.18632/oncotarget.4981. Oncotarget. 2015. PMID: 26293675 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
